Cryopreserved mobilized autologous blood progenitors stored for more than 2 years successfully support blood count recovery after high-dose chemotherapy

References

• Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte–macrophage colony-stimulating factor. Blood. 1989;74:1905–14.
   PubMed Web of Science ®Google Scholar
• Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, . Granulocyte–macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet. 1989;2:580–4.
   PubMed Web of Science ®Google Scholar
• Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, . Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992;339:640–4.
   PubMed Web of Science ®Google Scholar
• Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood. 1994;83:3808–14.
   PubMed Web of Science ®Google Scholar
• Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007;82:463–72.
   PubMed Web of Science ®Google Scholar
• Heal JM, Brightman A. Cryopreservation of hematopoietic progenitor cells collected by hemapheresis. Transfusion. 1987;27:19–22.
   PubMed Web of Science ®Google Scholar
• Hogge DE, Lambie K, Sutherland HJ, Benny WB, Dalal B, Currie C, . Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplant. 2000;25:589–98.
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant. 1998;4:84–92.
   PubMedGoogle Scholar
• Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol. 1993;21:508–14.
   PubMed Web of Science ®Google Scholar
• Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, . Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991;77:400–9.
   PubMed Web of Science ®Google Scholar
• Pecora AL. Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients. Bone Marrow Transplant. 1999;23:S7–12.
   PubMedGoogle Scholar
• Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, . An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–9.
   PubMed Web of Science ®Google Scholar
• Parkins MD, Bahlis N, Brown C, Savoie L, Chaudhry A, Russell JA, . Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation. Bone Marrow Transplant. 2006;38:609–14.
   Google Scholar
• Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS. Long-term engraftment stability of peripheral blood stem cells cryopreserved using the dump-freezing method in a −80 degrees C mechanical freezer with 10% dimethyl sulfoxide. Int J Hematol. 2001;73:245–50.
   Google Scholar
• Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, . Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003; 349:2495–502.
   PubMed Web of Science ®Google Scholar
• Spurr EE, Wiggins NE, Marsden KA, Lowenthal RM, Ragg SJ. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5–14 years) cryostorage. Cryobiology. 2002;44:210–7.
   PubMedGoogle Scholar
• Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, . Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002;4:157–63.
   PubMed Web of Science ®Google Scholar
• Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant. 1996;17:425–30.
   Google Scholar
• Aird W, Labopin M, Gorin NC, Antin JH. Long-term cryopreservation of human stem cells. Bone Marrow Transplant. 1992;9:487–90.
   PubMed Web of Science ®Google Scholar
• Liseth K, Ersvaer E, Abrahamsen JF, Nesthus I, Ryningen A, Bruserud O. Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion. 2010; Vol 49 – Issue 8, 1709– 19 Aug 2009.
   Google Scholar
• Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol. 1994;22:1003–10.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy. 2009;11:595–605.
   PubMed Web of Science ®Google Scholar
• Sutherland HJ, Eaves AC, Eaves CJ. Quantitative assays for human hemopoietic progenitor cells. Gee AP. Bone Marrow Processing and Purging: A Practical Guide. Boca Raton: CRC Press Inc.; 1991. 155–71.
   Google Scholar
• Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F, . Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood. 2002;99:731–5.
   PubMed Web of Science ®Google Scholar
• Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol. 1995; 13:588–95.
   PubMed Web of Science ®Google Scholar
• Glaspy JA, Shpall EJ, LeMaistre CF, Briddell RA, Menchaca DM, Turner SA, . Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood. 1997;90:2939–51.
   PubMed Web of Science ®Google Scholar
• Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood. 1988;71:723–7.
   PubMed Web of Science ®Google Scholar
• Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, . Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood. 1993; 81:3158–63.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Dregger P, Suttorp M, Rohwedder E, Haferlach T, Loffler H, . Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood. 1995;85: 1666–72.
   PubMed Web of Science ®Google Scholar
• Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, . Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood. 1995;85:1659–65.
   PubMed Web of Science ®Google Scholar
• Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 2000;18:1360–77.
   PubMed Web of Science ®Google Scholar
• FACT-JACIE. International Standards for Cellular Therapy Product Collection, Processing and Administration. FACT-JACIE, Nebraska; 2006. 96–7.
   Google Scholar